Study Launched to Uncover the Mysteries of Chronic Fatigue Syndrome

Researchers from the Centers for Disease Control and Prevention (CDC) and Emory University School of Medicine in Atlanta recently launched the most comprehensive population-based clinical study to date of patients with chronic fatigue syndrome (CFS). The study includes about 90 patients from Atlanta who will participate in the three-day in-patient clinical trial. Researchers hope results […]

Heparin Contamination Was Deliberate Act to Cut Costs?

Contamination of the worldwide heparin supply, which resulted in a substantial increase in adverse events and an estimated 81 deaths in the US, appears to have been a deliberate act to increase profits in Chinese workshops.

New Data Will Help Guide Prescribing of Celecoxib

A new meta-analysis of six randomized trials involving the cyclooxygenase-2 (COX-2) inhibitor celecoxib (Celebrex, Pfizer) should help direct physicians who still want to prescribe this drug [1]. Dr Scott D Solomon (Brigham and Women's Hospital, Boston, MA) presented the findings of the cross-trial safety analysis at a late-breaking trials session here at the American College […]

What Every Physician Should Know About the RUC

Introduction To paraphrase Winston Churchill, never have so many physicians and other health care professionals owed so much to so few. The "few" in this case are the 29 members of the American Medical Association/Specialty Society Relative Value Scale Update Committee, or RUC (rhymes with "truck") for short. The RUC's recommendations to the Centers for […]

AHA Statement Takes Aim at Hypertension Resistant to Triple-Drug Therapy

News Author: Steve StilesCME Author: Charles Vega, MD A new statement from the American Heart Association zeroes in on a group it says may make up 20% to 30% of patients with hypertension but has received only limited attention in formal guidelines, probably because they have been targeted in few clinical trials [1]. The document […]